Understanding exercise intolerance in patients with non-obstructive hypertrophic cardiomyopathy
Exercise Intolerance in Non Obstructive Hypertrophic Cardiomyopathy
This study is looking at how exercise affects people with non-obstructive hypertrophic cardiomyopathy (HCM) and aims to find out if exercise training can help improve heart function and make it easier for them to be active, ultimately enhancing their quality of life.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California, San Francisco NIH-funded |
| Lab location | 1 site (San Francisco, United States) |
| Project ID | NIH-11045757 on NIH RePORTER |
What this research studies
This research investigates how exercise intolerance affects patients with non-obstructive hypertrophic cardiomyopathy (HCM), a common genetic heart disease. The study aims to explore the relationship between myocardial mechanics, microvascular ischemia, and exercise capacity in these patients. By utilizing advanced imaging techniques like PET and CMR, researchers will assess how exercise training may improve heart function and overall exercise tolerance. The goal is to identify effective therapeutic strategies that could enhance the quality of life for individuals with this condition.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with non-obstructive hypertrophic cardiomyopathy who experience exercise intolerance.
Not a fit: Patients with obstructive hypertrophic cardiomyopathy or those without exercise intolerance may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new exercise-based therapies that significantly improve the exercise capacity and quality of life for patients with non-obstructive HCM.
How similar studies have performed: Previous research has shown promising results in understanding exercise capacity in HCM, but this specific focus on non-obstructive cases is relatively novel.
Where this research is happening
San Francisco, United States
- University of California, San Francisco — San Francisco, United States (Active)
Researchers
- Principal investigator: Abraham, Theodore P — University of California, San Francisco
- Study coordinator: Abraham, Theodore P
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.